Love Me Love My Phages

  • Home
  • Love Your Phages
  • George Eliava Institute
  • eat-me-the-soviet-method-for-attacking-infection
  • Phage Therapy
  • phage-therapy-and-cholera---1
  • Cocktail That Cures
  • Phage Therapy in Agriculture and Animals - 1
  • Phage Therapy_Past History and Future Prospects
  • bdellovibrio-a-predatory-bacteria -1
  • uk - first-superbug-phage-clinical-trial
  • Bacteriophages and Sleeping Sickness
  • The MRSA Problem
  • The Use of Bacteriophages Against Infections
  • Virises vs Superbugs
  • Bacterias natural born killers
  • The Killers Within Prologue
  • The Killers Within - The Silent War
  • Bacteriophages as Antibiotics
  • The Cocktail That Cures
  • Phage Therapy - Abstracts From The Scientific Area
  • Phage production goes large scale
  • Novel alternatives to antibiotics
  • Phages channel their resources
  • Viral defense against Listeria in Foods
  • Bacteriophage Therapy a Revitalized Therapy
  • US Phage Therapy Clinics in Mexico
  • E coli Phage Therapy Implications
  • Phage Therapy and E coli in Livestock
  • Bacteriophage Therapy in Western Medicine
  • Scientists Discover Exciting New MRSA Fighter
  • The New Antibiotics
  • Support Those Who Help Us Make This Site Possible
  • SCIENCE FRIDAY - MP3 FILES
  • Division M- Bacteriophage
  • A Glossary Defining Some Terms For Phage Biology
  • Bacteriophages on the World Wide Web
  • Major Discoveries Made With Bacteriophages
  • W W C Topley and the Missing Phage Reference
  • Lives At Risk From Drug Resistant Bug
  • A Killer In Our Midst
  • Adelaide RAH Superbug Outbreak Worsens
  • Bug At Adelaide RAH Infects More
  • US Meat Sector Target Of Listeria Technology
  • Microscope Dangers
  • Therapy with a Nonreplicating GM Phage
  • Phage Therapy - The Escherichia coli Experience
  • E-coli Phage Human Safety Tests in Water
  • Thank Yous
  • Phages in Treating Trial of e coli in Chickens
  • Phages_Pseudomonas aeruginosa Septicemia in Mice
  • Hello World
  • Using Phage Viruses to Help Fight Infection
  • Georgia an Unlikely Stronghold for Bacteriophage
  • Bacteriophage method to antimicrobial drugs
  • 48 Hours CBS on Bacteriophages
  • An infant in septic shock _ Commentary
  • An infant in septic shock _ Where Now
  • Hospital horror
  • Anthrax stopper
  • Phage R and D Companies
  • Viruses vs Superbugs
  • The Next Phage
  • Statins Reduce Infection
  • Statins vs Bacteria
  • STATINS REDUCE SEPIS IN DIALYSIS
  • Statins Can Prevent A Second Stroke
  • Contact - Love Me Love My Phages
  • Statins May Help One Brit in Six Reach 100
  • Statins Help Slow Down Multiple Sclerosis
  • New Way To Fight Superbugs inc With Tears
  • Phages vs Fireblight Disease - 1
  • Company Develops Natural Way to Fight E coli
  • First 'virophage' could take the fight to viruses
  • Sputnik virophage
  • Virophage - the virus eater
  • Phage Biotech Israel


Activity of E. coli phages have implications for phage therapy.

Obesity, Fitness & Wellness Week.  Sept 11, 2004 p633.

Full Text: COPYRIGHT 2004 NewsRX



2004 SEP 11 - (NewsRx.com & NewsRx.net) -- The in vitro and in vivo bacteriolytic activities of Escherichia coli phages have implications for phage therapy.

"Four T4-like coliphages with broad host ranges for diarrhea-associated Escherichia coli serotypes were isolated from stool specimens from pediatric diarrhea patients and from environmental water samples. All four phages showed a highly efficient gastrointestinal passage in adult mice when added to drinking water. Viable phages were recovered from the feces in a dose-dependent way. The minimal oral dose for consistent fecal recovery was as low as 10[superscript]3 PFU of phage per mL of drinking water," investigators in Switzerland report.

"In conventional mice, the orally applied phage remained restricted to the gut lumen, and as expected for a noninvasive phage, no histopathological changes of the gut mucosa were detected in the phage-exposed animals," said Sandra Chibani-Chennoufi at Nestec Ltd. in Switzerland and collaborators in Switzerland, the U.S., and Bangladesh. "E. coli strains recently introduced into the intestines of conventional mice and traced as ampicillin-resistant colonies were efficiently lysed in vivo by phage added to the drinking water. Likewise, an in vitro phage-susceptible E. coli strain freshly inoculated into axenic mice was lysed in vivo by an orally applied phage, while an in vitro-resistant E. coli strain was not lysed."

"In contrast, the normal E. coli gut flora of conventional mice was only minimally affected by oral phage application despite the fact that in vitro the majority of the murine intestinal E. coli colonies were susceptible to the given phage cocktail," reported the researchers. "Apparently, the resident E. coli gut flora is physically or physiologically protected against phage infection."

Chibani-Chennoufi and her coauthors published their study in Antimicrobial Agents and Chemotherapy (In vitro and in vivo bacteriolytic activities of Escherichia coli phages: Implications for phage therapy. Antimicrob Agents Chemother, 2004;48(7):2558-2569).

For additional information, contact Harald Brussow, Nestle Research Center, Nestec Ltd., Vers-chez-les-Blanc, CH-1000 Lausanne 26, Switzerland. E-mail: harald.bruessow@rdls.nestle.com.

The publisher of the journal Antimicrobial Agents and Chemotherapy can be contacted at: American Society for Microbiology, 1752 N Street NW, Washington, DC 20036-2904, USA.

The information in this article comes under the major subject areas of Gastroenterology Vaccine, Vaccine Development, Immunology, Immunotherapy, and Gastroenterology.

This article was prepared by Obesity, Fitness & Wellness Week editors from staff and other reports. Copyright 2004, Obesity, Fitness & Wellness Week via NewsRx.com & N


http://galenet.galegroup.com/servlet/HWRC/hits?r=d&origSearch=false&bucket=per&o=&rlt=2&n=10&l=d&items=0&c=28&tcit=0_1_0_0_0_0&docNum=A121589640&sgPhrase=false&locID=cityadelaide&secondary=false&t=RK&s=1&SU=Phage+TherapyewsRx.net





 

Make a Free Website with Yola.